The US pharmacovigilance market is expanding due to rising chronic diseases, stringent FDA regulations, and AI-driven ...

Though pharmacovigilance has improved in recent years, there's still much room for improvement, says Steve Jolley. Here he outlines some problem areas in drug safety that need attention.

Regulatory Shifts and Data-Sharing Advancements Fuel Global Pharmacovigilance Growth, Opening Doors for Seamless Compliance ...

Good communication is required between pre-clinical, medical and pharmacovigilance groups to identify potential safety issues and develop the safety profile of new cancer drugs. References 1.

This multi-scale protein modeling approach may reduce the time it takes to bring pharmaceuticals to market and may have significant implications for an array of biotechnology applications with the ...

The Drug Safety Research Unit (DSRU) has announced the appointment of Linda Härmark as its new director.

The Fellow will have the opportunity to rotate across the various Sanofi Global Business Units within Pharmacovigilance. The Fellow will also gain exposure to other functional areas based on ...

Researchers from the Drug Safety Research Unit are calling for the robust monitoring of the safety of lecanemab, a promising new drug to treat Alzheimer’s Disease (AD). In a review article, published ...

Glenwood Services Philippines Inc. (GSPI) registered with the Board of Investments (BOI) to launch the first pharmaceutical ...